Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009;44(7):793-8.
doi: 10.1007/s00535-009-0056-4. Epub 2009 Apr 29.

Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma

Affiliations
Free article

Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma

Masato Narita et al. J Gastroenterol. 2009.
Free article

Abstract

Background: Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) is an MRI contrast agent with perfusion and hepatoselective properties. The purpose of the study was to examine uptake of Gd-EOB-DTPA in the hepatobiliary phase in hepatocellular carcinoma (HCC).

Methods: A retrospective analysis of 22 patients with HCC who underwent preoperative Gd-EOB-DTPA-enhanced MRI was performed. Enhancement ratios (ERs) and expression levels of the organic anion transporter (OATP) 1B3 protein were examined.

Results: Gd-EOB-DTPA accumulated in the hepatobiliary phase in 6 of the 22 cases. All 6 Gd-EOB-DTPA-positive cases were moderately differentiated HCC, but 11 other moderately differentiated HCCs did not show Gd-EOB-DTPA uptake. Histopathologically, 4 Gd-EOB-DTPA-positive HCCs and 5 Gd-EOB-DTPA-negative HCCs produced bile. HCCs with Gd-EOB-DTPA uptake overexpressed OATP1B3 compared with HCCs without Gd-EOB-DTPA uptake, and OATP1B3 levels were significantly correlated with ERs (r=0.91, P<0.0001).

Conclusions: Uptake of Gd-EOB-DTPA in HCC is determined by expression of OATP1B3 rather than by tumor differentiation or bile production.

PubMed Disclaimer

Comment in

References

    1. J Pharmacol Exp Ther. 1999 Jul;290(1):153-7 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 2006 Mar;372(6):432-43 - PubMed
    1. Radiology. 1995 Jun;195(3):785-92 - PubMed
    1. Cancer Biol Ther. 2005 Aug;4(8):815-8 - PubMed
    1. Annu Rev Biochem. 2002;71:537-92 - PubMed

MeSH terms

Substances